Oncolytics Biotech Inc (ONCY) stock
ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.39−0.05 (-11.29%)
Close on Nov 19, 2026Market cap $49.81MP/E –Yield –
Oncolytics Biotech net income
Net income is the profit left for shareholders after every expense, interest and tax.
No net income figures for Oncolytics Biotech
Oncolytics Biotech has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?